Enliven Therapeutics Chief Medical Officer Helen Louise Collins Reports Sale of $192,342 in Common Shares
Bitget2026/10/21 21:52- Enliven Therapeutics Chief Medical Officer Helen Louise Collins sold 5,000 common shares on October 19, 2026.
- The sale price was $38.4684 per share.
- Collins also exercised stock options for 5,000 common shares at $2.48 per share on the same date.
- Following the transactions, she directly held 25,000 common shares and 101,268 stock options.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Client nodes, console, and API were not modified; Chainstack discloses attacker used the ARTEX framework
Elon Musk changes his stance! Tesla (TSLA.US) delays Cybertruck production halt to late summer 2027, just two days after suggesting “refund deposits”
Elon Musk stated that Cybertruck production will be extended until late summer 2027 to clear the order backlog, and Tesla's stock price rose by about 4%.
Japanese dovish policymaker urges "slow down": Price increases are not driven by demand, rate hikes may drag down the economy and inflation
Toichiro Asada, a member of the Bank of Japan's Policy Board, stated that the central bank needs to remain cautious and closely monitor the impact of rate hikes on the economy, as rising interest rates pose the risk of suppressing the inflation trend.
Crypto prices
More
